GLP-1s Boost IBD Outcomes in Patients With T2D and Obesity ...Middle East

The use of GLP-1s is linked to improved inflammatory bowel disease outcomes in patients with concomitant inflammatory bowel disease and type 2 diabetes, specifically in those with obesity. Medscape Medical News

Hence then, the article about glp 1s boost ibd outcomes in patients with t2d and obesity was published today ( Friday 06/12/2024 - 01:08 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( GLP-1s Boost IBD Outcomes in Patients With T2D and Obesity )

Also on site :

• Sabrina Carpenter, Bad Bunny, Taylor Swift & More Nominated for 2026 Webby Awards
• Hezbollah Denies Bahraini Interior Ministry& 039;s Baseless Allegations
• The 5 TV Premieres We're Most Excited for in April 2026